Tag: BioNTech SE ADR

More than 3 million people have died of COVID-19 and more than 140 million have been infected

The global death toll from the coronavirus-borne illness COVID-19 climbed above 3 million on Saturday and the case tally rose above 140 million, a day...

U.S. COVID vaccine program speeds up to about 3 million doses a day in the past week

The U.S. COVID-19 vaccine program continues to kick into high gear, setting a record Saturday of more than four million doses administered, although experts continue...

WHO declared a pandemic one year ago today

One year after the World Health Organization declared COVID-19 a global pandemic, more than 118 million cases of the coronavirus-borne illness have been confirmed around...

Single dose of AstraZeneca or Pfizer COVID-19 vaccine cuts hospitalization risk by up to 80%, study shows

A single dose of either the AstraZeneca–Oxford vaccine or the Pfizer–BioNTech COVID-19 shot cuts the risk of hospital admission among older adults by more than...

AstraZeneca vaccine may reduce spread by 67% — and protection remains over 3-month dosage gap

A single dose of the AstraZeneca AZN, -0.88% COVID-19 vaccine offers 76% protection for up to three months after the first injection and appears to...

Sanofi teams up with BioNTech and Pfizer to help fix Europe’s vaccine shortage

Sanofi SAN, +0.01% will help manufacture millions of doses of the COVID shot developed by rivals BioNTech and Pfizer PFE, +0.08% to help speed up...

Open all hours: Around-the-clock vaccination sites to be piloted in England in COVID-19 drive

The U.K. government will pilot the first 24-hour vaccination sites by the end of the January, as the country presses ahead with the biggest vaccine...

Pfizer–BioNTech vaccine appears to protect against U.K. and South African COVID-19 strains, study finds

The COVID-19 vaccine developed by Pfizer and BioNTech appears to provide protection against the new highly contagious U.K. and South African variants, according to a...

‘Wear masks when seeing family over Christmas,’ WHO urges Europeans, as regulator accelerates COVID vaccine timeline

Europeans should wear masks at family gatherings over Christmas amid a spike in coronavirus cases in the region, the World Health Organization has advised. “Despite...

First COVID-19 vaccine receives emergency approval in U.S.

The Food and Drug Administration authorized BioNTech and Pfizer Inc.’s COVID-19 vaccine Friday evening, which will make it the first vaccine to reach Americans during...

What to expect from the FDA’s important COVID-19 vaccine meeting Thursday

An all-day regulatory meeting scheduled to take place Thursday is the next step toward the likely authorization of the first COVID-19 vaccine in the U.S....

World watches as first person receives Pfizer-BioNTech COVID shot

Manufacturing delays mean just 4 million doses of the vaccine candidate being developed by drugmaker AstraZeneca AZN, +0.97% and the University of Oxford will be...

No vaccine, no entry? Will bars and restaurants turn away Brits without COVID-19 jab?

Getting vaccinated in the U.K. will be voluntary, but some venues may want proof. daniel leal-olivas/Agence France-Presse/Getty Images Restaurants, cinemas and even sporting venues may...

U.S. is ‘in the middle of the Fight of the Century,’ says former CDC head as cases rise in 45 states, hospitalizations set record

The U.S. case tally from the coronavirus illness COVID-19 climbed above 12.48 million on Tuesday, and hospitalizations again reached record levels, with 45 states reporting...

U.S. moves closer to 200,000 daily COVID cases; Birx and Fauci urge Americans to follow safety measures over Thanksgiving

The global case tally of the coronavirus illness COVID-19 climbed above 57 million on Friday, and the U.S. moved closer to 200,000 cases in a...

New ‘mega labs’ to open in early 2021, doubling U.K. government’s COVID testing capacity

Facilities with the capacity to process 600,000 diagnostic checks a day are set to open in the Midlands in England and in Scotland in early...

There are four coronavirus vaccines in late-stage studies — here’s how they differ

Johnson & Johnson’s investigational COVID-19 vaccine entered Phase 3 clinical trials this week, making it the fourth vaccine candidate in the U.S. to do so...